Factors influencing treatment escalation from long-acting muscarinic antagonist monotherapy to triple therapy in patients with COPD: a retrospective THIN-database analysis

PURPOSE: Inappropriate use of an inhaled corticosteroid (ICS) for COPD has clinical and economic disadvantages. This retrospective analysis of The UK Health Improvement Network (THIN) database identified factors influencing treatment escalation (step-up) from a long-acting muscarinic antagonist (LAM...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurst, John R, Dilleen, Maria, Morris, Kevin, Hills, Siân, Emir, Birol, Jones, Rupert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842770/
https://www.ncbi.nlm.nih.gov/pubmed/29551894
http://dx.doi.org/10.2147/COPD.S153655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842770/
https://www.ncbi.nlm.nih.gov/pubmed/29551894
http://dx.doi.org/10.2147/COPD.S153655

Ejemplares similares